Dementia: Blood-based markers may help spot dementia risk, says new study
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
Dementia is an umbrella term for groups of symptoms that surface as a result of progressive brain decline. Much is still to be understood about dementia but research has made considerable headway. The focus is primarily on early intervention – if dementia risk can be highlighted ahead of time – it offers a window to bolster the brain’s defences against developing it.
A new study published in the journal Nature today advances this important endeavour.
Researchers in Sweden found levels of certain blood-based proteins predicted worsening memory and thinking in a group of people with mild cognitive impairment (MCI).
Why is this significant? MCI is an umbrella term given to a noticeable and measurable decline in a person’s memory or thinking, which does not interfere with activities of their daily life.
It can be a precursor to dementia – around ten to 15 percent of those living with MCI go on to develop dementia per year.
To arrive at their conclusion, researchers looked at two groups of people with MCI and measured levels of a form of tau – a hallmark Alzheimer’s protein in people’s blood. This form of tau is known as ptau-181.
They also measured levels of another protein called neurofilament light chain – an indicator of ongoing damage in the brain.
They found a combined measure of both of these proteins predicted a decline in memory and thinking in the volunteers over a four-year period.
The team also looked at other blood-based markers, but these did not strongly predict a change in memory and thinking.
How to live longer: The amount of tea you should drink a day to reduce your dementia risk [TIPS]
Coronavirus symptoms: Day-to-day breakdown of how virus develops including symptoms [INSIGHT]
How to sleep: Signs of bruxism and what you can do about it [ADVICE]
Dr Sara Imarisio, Head of Research at Alzheimer’s Research UK, said: “Like dementia, MCI is an umbrella term describing several symptoms, and can be caused by a number of different underlying diseases. We know that over 50% of people with MCI will go on to develop dementia, and it is important that we try to identify those who will and those who will not progress to be able to offer appropriate treatment and advice.
“Blood tests for predicting the risk of Alzheimer’s disease are getting ever more advanced. In this well-designed study, levels of a form of tau coupled with a protein indicating neurodegeneration were able to predict who developed more severe memory and thinking problems. However, further studies in larger groups of people will need to replicate and verify the accuracy of this approach.
“One intriguing finding is that these markers predicted a change in memory in thinking in both people with and without the Alzheimer’s risk gene, APOE4. Genetic testing can present ethical challenges, especially as it can have implications for a patient’s family members. A blood test that does not need a genetic test would be most beneficial in the clinic.
“While there are other types of biological test that can help determine the cause and likely course of memory and thinking problems, blood tests are much more affordable than brain scans and more straightforward and acceptable to people than a lumbar puncture.
Dr Imarisio added: “Any future dementia treatments are likely to need to be given early in the disease process, making it even more important to take findings like these forwards to improve how we diagnose early memory and thinking problems. We need to see a shift in how we think and deal with MCI including ways to bring blood-based markers into routine clinical practice.”
Other risk factors for dementia
Researchers have discovered several important factors that affect our risk of developing dementia.
“These include age and genetics, but also medical conditions and lifestyle choices,” according to the Alzheimer’s Society (AS).
According to the AS, many of the most important avoidable risk factors for dementia tend to first appear in mid-life, between the ages of about 40 and 64.
Chronic conditions such as high blood pressure and type 2 diabetes fall into this category.
“Age is the strongest known risk factor for dementia. While it is possible to develop the condition earlier – at least one in 20 people with dementia developed it at age under 65,” it adds.
What are the main symptoms of dementia?
According to the NHS, dementia symptoms may include problems with:
- Memory loss
- Thinking speed
- Mental sharpness and quickness
- Language, such as using words incorrectly, or trouble speaking
- Difficulties in doing daily activities.
“People with dementia can lose interest in their usual activities, and may have problems managing their behaviour or emotions,” adds the health body.
Source: Read Full Article